病理分期-话题@MedSci

#病理分期#

5篇内容 | 736人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1953666, encodeId=ec09195366696, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=BMC Cancer：淋巴结检查数目（NELNs）对病理分期为 T1-3N0M0的食管鳞状细胞癌患者预后影响, objectType=article, longId=295098, objectId=2c292950982d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c292950982d, replyNumber=0, likeNumber=36, createdTime=2022-08-04, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c292950982d, moduleTitle=BMC Cancer：淋巴结检查数目（NELNs）对病理分期为 T1-3N0M0的食管鳞状细胞癌患者预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c292950982d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1953665, encodeId=746819536658e, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=一文读懂肿瘤病理分期：早/中/晚期或I/II/III/IV期, objectType=article, longId=220738, objectId=f8ef220e3862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ef220e3862, replyNumber=0, likeNumber=51, createdTime=2022-04-07, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ef220e3862, moduleTitle=一文读懂肿瘤病理分期：早/中/晚期或I/II/III/IV期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8ef220e3862)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1953664, encodeId=37a3195366484, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=J Urol：膀胱切除术前新辅助化疗对肌肉浸润性膀胱癌的病理分期和生存预后的益处, objectType=article, longId=212006, objectId=50c321200648, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50c321200648, replyNumber=0, likeNumber=37, createdTime=2021-12-06, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50c321200648, moduleTitle=J Urol：膀胱切除术前新辅助化疗对肌肉浸润性膀胱癌的病理分期和生存预后的益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50c321200648)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1953663, encodeId=73771953663df, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=宫颈癌FIGO2018分期：临床分期还是手术病理分期？, objectType=article, longId=160368, objectId=4b7116036840, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b7116036840, replyNumber=0, likeNumber=49, createdTime=2019-12-25, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b7116036840, moduleTitle=宫颈癌FIGO2018分期：临床分期还是手术病理分期？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b7116036840)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1953662, encodeId=ffd8195366281, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=JCO：食管腺癌新辅助化疗降低病理分期与生存预后密切相关, objectType=article, longId=38892, objectId=e4943889206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4943889206, replyNumber=0, likeNumber=59, createdTime=2014-08-20, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4943889206, moduleTitle=JCO：食管腺癌新辅助化疗降低病理分期与生存预后密切相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4943889206)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

病理分期

2020-05-29

ssnine (审核中...)

前往app查看评论内容

#病理分期#

BMC Cancer：淋巴结检查数目（NELNs）对病理分期为 T1-3N0M0的食管鳞状细胞癌患者预后影响

2022-08-04

ssnine (审核中...)

前往app查看评论内容

#病理分期#

一文读懂肿瘤病理分期：早/中/晚期或I/II/III/IV期

2022-04-07

ssnine (审核中...)

前往app查看评论内容

#病理分期#

J Urol：膀胱切除术前新辅助化疗对肌肉浸润性膀胱癌的病理分期和生存预后的益处

2021-12-06

ssnine (审核中...)

前往app查看评论内容

#病理分期#

宫颈癌FIGO2018分期：临床分期还是手术病理分期？

2019-12-25

ssnine (审核中...)

前往app查看评论内容

#病理分期#

JCO：食管腺癌新辅助化疗降低病理分期与生存预后密切相关

2014-08-20

科室
- - 订阅+
  - 更多科室
工具
服务